Breaking News Bar

Business News and Information

AstraZeneca waiting for FDA to greenlight restart of US drug trial

AstraZeneca says it's still waiting on federal approval to resume the U.S. clinical trial of its COVID-19 vaccine candidate nearly three weeks after the study was halted over safety concerns.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear